Non-invasive Measurement of Central Hemodynamics by Electrical Impedance Tomography

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2017-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the ability to measure central hemodynamics and heart-lung interactions non-invasively by electrical impedance tomography and compare it to clinically established hemodynamic monitoring.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Electromagnetic Tracking of Devices During Interventional Procedures - A Cryoablation Study

NCT01401777

Kidney Tumors

WITHDRAWN

Developing Methods for Reconstructing Electrical Heart Activity

NCT03947021

Heart Diseases Cardiac Conduction Defect

UNKNOWN NA

Imaging Sodium and Lymphatics in Lymphedema

NCT05242900

Lymphedema of Leg Lymphedema, Secondary Lymphedema Related Fibrosis

ACTIVE_NOT_RECRUITING

Cardiac Magnetic Resonance Assessment for Heart Failure With Preserved Ejection Fraction

NCT04063579

Heart Failure With Preserved Ejection Fraction

COMPLETED NA

Attenuation Corrected Cardiac SPECT Using the GE Hawkeye Camera System

NCT00587730

Cardiac Disease

TERMINATED PHASE2/PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to evaluate the ability to measure central hemodynamics and heart-lung interactions non-invasively by electrical impedance tomography and compare it to clinically established hemodynamic monitoring.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Comparison of Availability for Prediction of Volume Responsiveness Comparison of Limits of Agreement for Invasive and Non-invasive Measurement of Stroke Volume Variation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

study group

comparison of ability to predict volume responsiveness and precision of measurement of stroke volume variation assessed by electrical impedance tomography in comparison to clinically established invasive hemodynamic monitoring devices, i.e. arterial pulse contour analysis during volume loading procedures

Group Type OTHER

volume loading

Intervention Type OTHER

volume loading according to functional parameters of cardiac preload, i.e. stroke volume variations measured by arterial pulse contour analysis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

volume loading

volume loading according to functional parameters of cardiac preload, i.e. stroke volume variations measured by arterial pulse contour analysis

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>18 years
* Indication for advanced invasive hemodynamic monitoring due to operative procedure
* Necessity of postoperative invasive ventilation

Exclusion Criteria

* Age \<18 years
* known affections cardiac function
* presence of cardiac arrhythmias
* contraindication for placement of central venous or femoral artery catheter

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No